Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dunn

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
The Pediatric Infectious Disease Journal|April 3, 2008
HIV-1 drug resistance in HIV-1-infected children in the United Kingdom from 1998 to 2004Rana Chakraborty, Colette J Smith, David Dunn, et al.
AIDS (London, England)|October 1, 2019
No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIVJames E Burns, Oliver T Stirrup, David Dunn, et al.
Plos One|November 13, 2012
Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) studyHuw Price, Loveleen Bansi, Caroline A Sabin, et al.
BMJ (Clinical Research Ed.)|November 22, 2005
Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational studyPatricia Cane, Ian Chrystie, David Dunn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized TrialJennifer A Thompson, Cissy Kityo, David Dunn, et al.
Plos One|May 7, 2013
Neurocognitive function in HIV infected patients on antiretroviral therapyAlan Winston, Alejandro Arenas-Pinto, Wolfgang Stöhr, et al.
AIDS Research and Human Retroviruses|August 11, 2015
Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East AfricaKatherine A Sutherland, Ruth L Goodall, Adele McCormick, et al.
BMC Public Health|April 27, 2019
Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trialAda R Miltz, Fiona C Lampe, Loraine J Bacchus, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 20, 2017
Mapping and confirmation of loci for salt tolerance in a novel soybean germplasm, Fiskeby IIITuyen D Do, Tri D Vuong, David Dunn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipientsKhalid Khwaja, Massimo Asolati, James Harmon, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
The Pediatric Infectious Disease Journal|April 3, 2008
HIV-1 drug resistance in HIV-1-infected children in the United Kingdom from 1998 to 2004Rana Chakraborty, Colette J Smith, David Dunn, et al.
AIDS (London, England)|October 1, 2019
No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIVJames E Burns, Oliver T Stirrup, David Dunn, et al.
Plos One|November 13, 2012
Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) studyHuw Price, Loveleen Bansi, Caroline A Sabin, et al.
BMJ (Clinical Research Ed.)|November 22, 2005
Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational studyPatricia Cane, Ian Chrystie, David Dunn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized TrialJennifer A Thompson, Cissy Kityo, David Dunn, et al.
Plos One|May 7, 2013
Neurocognitive function in HIV infected patients on antiretroviral therapyAlan Winston, Alejandro Arenas-Pinto, Wolfgang Stöhr, et al.
AIDS Research and Human Retroviruses|August 11, 2015
Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East AfricaKatherine A Sutherland, Ruth L Goodall, Adele McCormick, et al.
BMC Public Health|April 27, 2019
Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trialAda R Miltz, Fiona C Lampe, Loraine J Bacchus, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 20, 2017
Mapping and confirmation of loci for salt tolerance in a novel soybean germplasm, Fiskeby IIITuyen D Do, Tri D Vuong, David Dunn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipientsKhalid Khwaja, Massimo Asolati, James Harmon, et al.
Pageof 15